Академический Документы
Профессиональный Документы
Культура Документы
News
Contact: Gary Gatyas
IMS Health
(610)834-5338
ggatyas@us.imshealth.com
MEDIA STATEMENT
IMS Health issued the following statement regarding its pending acquisition of SDI.
IMS Health announced today that it has signed a definitive agreement to acquire
SDI, a privately held healthcare market insights and analytics firm serving the U.S.
market. Terms of the transaction were not disclosed. The agreement is subject to
pre-merger notification requirements of the Hart-Scott-Rodino Antitrust
Improvements Act of 1976, which will be filed shortly.
The acquisition will enable more robust patient and specialty analytics, and will give
IMS the ability to provide a broader set of stakeholders with clinically-rich insights
from all healthcare channels, including hospitals, providers and pharmacies. The
addition of SDI¶s complementary information assets and capabilities positions IMS
to improve existing offerings, fuel new investments and deliver greater innovation
and value to a healthcare industry that is seeking to drive increased efficiencies as
a result of significant, ongoing pressure to reduce costs and expand patient access.
About IMS
Operating in more than 100 countries, IMS Health is the world¶VOHDGLQJ
provider of market intelligence to the pharmaceutical and healthcare industries.
With more than 55 years of industry experience, IMS Health offers leading-edge
PDUNHWLQWHOOLJHQFHSURGXFWVDQGVHUYLFHVWKDWDUHLQWHJUDOWRFOLHQWV¶GD\-to-day